BN Business News
Add your company to Business Communicator →

Regulation & law · 06/05/2022Updated: 10/17/2026 · 1 min read

Patheon Pharmaceuticals Inc. Applies to Register as Bulk Manufacturer of Controlled Substances

Summary

Patheon Pharmaceuticals Inc. has submitted an application to the regulatory authorities to be registered as a bulk manufacturer of controlled substances, a key step in the production and distribution of certain medications.

Original source language: Federal Register — Justice DepartmentOpen original release →

Explore insights

Business insights →